VIENNA, Austria—Semperit A.G. Holding expects to report an impairment loss of approximately $50 million for its medical sector, Sempermed, in the third quarter of 2022, the Austrian group has announced.
"Against the backdrop of the market dynamics for examination and protective gloves, the executive board reviewed the estimates and assumptions relevant to the valuation with regard to the medical sector," said a group statement Sept. 13.
"As a result, a probable impairment loss in the order of approximately €50 million (about $50.1 million) as of (Sept. 30), 2022 was identified for the segment assets of Sempermed," it added.